Clearmind Medicine Stock (NASDAQ:CMND)
Previous Close
$0.92
52W Range
$0.85 - $2.30
50D Avg
$1.16
200D Avg
$1.35
Market Cap
$4.98M
Avg Vol (3M)
$66.36K
Beta
-1.36
Div Yield
-
CMND Company Profile
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
CMND Performance
Peer Comparison
| Ticker | Company |
|---|---|
| WINT | Windtree Therapeutics, Inc. |
| CNSP | CNS Pharmaceuticals, Inc. |
| VRAX | Virax Biolabs Group Limited |
| IMMX | Immix Biopharma, Inc. |
| REVB | Revelation Biosciences, Inc. |
| QNRX | Quoin Pharmaceuticals, Ltd. |
| SONN | Sonnet BioTherapeutics Holdings, Inc. |
| CDIO | Cardio Diagnostics Holdings, Inc. |
| UNCY | Unicycive Therapeutics, Inc. |